US FDA allows lower-risk claim for 20 ZYN nicotine pouches

Top Framing Differences

• Left: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.
• Center: MANILA, Philippines — The US Food and Drug Administration (FDA) issued Modified Risk Tobacco Product orders for 20 variants of ZYN nicotine pouch products, allowing PMI US to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis,” the FDA said. The June 30 ruling marks the first time the US regulator has issued “modified-risk orders” for nicotine
• Right: Coverage gap: Currently unaddressed by verified outlets on this side of the spectrum.